Cargando…
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effect...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944431/ https://www.ncbi.nlm.nih.gov/pubmed/24611082 http://dx.doi.org/10.2174/1874192401408010006 |
_version_ | 1782306380648022016 |
---|---|
author | Morishita, Yoshiyuki Kusano, Eiji Nagata, Daisuke |
author_facet | Morishita, Yoshiyuki Kusano, Eiji Nagata, Daisuke |
author_sort | Morishita, Yoshiyuki |
collection | PubMed |
description | The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease. |
format | Online Article Text |
id | pubmed-3944431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-39444312014-03-07 Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis Morishita, Yoshiyuki Kusano, Eiji Nagata, Daisuke Open Cardiovasc Med J Article The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease. Bentham Open 2014-02-07 /pmc/articles/PMC3944431/ /pubmed/24611082 http://dx.doi.org/10.2174/1874192401408010006 Text en © Morishita et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Morishita, Yoshiyuki Kusano, Eiji Nagata, Daisuke Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title | Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title_full | Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title_fullStr | Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title_full_unstemmed | Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title_short | Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis |
title_sort | clinical implication of the renin-angiotensin-aldosterone blockers in chronic kidney disease undergoing hemodialysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944431/ https://www.ncbi.nlm.nih.gov/pubmed/24611082 http://dx.doi.org/10.2174/1874192401408010006 |
work_keys_str_mv | AT morishitayoshiyuki clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis AT kusanoeiji clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis AT nagatadaisuke clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis |